Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 5:44:160.
doi: 10.11604/pamj.2023.44.160.36748. eCollection 2023.

Effect of dexamethasone administration on gonadal-fertility functions in female albino rats

Affiliations

Effect of dexamethasone administration on gonadal-fertility functions in female albino rats

Fatima Yousif Mohammed et al. Pan Afr Med J. .

Abstract

Introduction: dexamethasone is misused for skin whitening with broad effects on steroidogenesis and ovarian functions. Here in we investigated the impact of dexamethasone administration on gonadotropin Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH), prolactin, and ovarian tissues in albino rats.

Methods: in the experimental study, 36 female albino rats weighting (140-162 g) were divided into three groups: control, normal dose received dexamethasone (8.3 μg/kg/day) and high dose (24.9 μg/kg/day), for 30 and 60 days. follicle stimulating hormone, luteinizing hormone, and prolactin (PRL) were measured. Histological ovarian sections were examined.

Results: luteinizing hormone, follicle stimulating hormone and prolactin significantly increased (p-value < 0.05) following dexamethasone treatment compared to control. The ovary sections showed degenerative tissue with necrosis of the Graafian follicles, stromal fibrosis, and vacuolation of the interstitial cells.

Conclusion: the study concludes that dexamethasone administration has a potentially adverse effect on gonadotropin, prolactin, and ovarian follicle cells in female albino rats.

Keywords: Dexamethasone; cosmetics; gonadotropins; infertility; lightener; prolactin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
comparison of the mean follicle stimulating hormone, luteinizing hormone and prolactin levels of study groups, following treatment with dexamethasone for 30 days
Figure 2
Figure 2
comparison of the mean follicle stimulating hormone, luteinizing hormone and prolactin levels of study groups, following treatment with dexamethasone for 60 days
Figure 3
Figure 3
histological section of ovary sections stained with (H and E): A) control group; B) treated with the low dose dexamethasone for 60 days; C) treated with a high dose for 30 days; D) treated with high dose for 60 days

Similar articles

References

    1. Dadzie OE. Unethical skin bleaching with glutathione. BMJ. 2016 Aug 31;354:i4386. - PubMed
    1. Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. Dermatol Clin. 2011 Jan;29(1):111–23. - PubMed
    1. Ahmed AE, Hamid ME. Use of Skin-Whitening Products by Sudanese Undergraduate Females: a Survey. J Racial Ethn Health Disparities. 2017 Apr;4(2):149–155. - PubMed
    1. Malathi M, Thappa DM. Systemic skin whitening/lightening agents: What is the evidence. Indian J Dermatol Venereol Leprol. 2013 Nov-Dec;79(6):842–6. - PubMed
    1. Orazizadeh M, Khorsandi LS, Hashemitabar M. Toxic effects of dexamethasone on mouse testicular germ cells. Andrologia. 2010 Aug;42(4):247–53. - PubMed